Oscar Health (OSCR)
(Delayed Data from NYSE)
$17.56 USD
-0.33 (-1.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.55 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
OSCR 17.56 -0.33(-1.84%)
Will OSCR be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OSCR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OSCR
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
Why Fast-paced Mover Oscar Health, Inc. (OSCR) Is a Great Choice for Value Investors
OSCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Despite Fast-paced Momentum, Oscar Health, Inc. (OSCR) Is Still a Bargain Stock
Oscar Health, Inc. (OSCR) Is Attractively Priced Despite Fast-paced Momentum
Oscar Health, Inc. (OSCR) Shows Fast-paced Momentum But Is Still a Bargain Stock
Other News for OSCR
Longleaf Partners Small-Cap Fund Q1 2024 Commentary
Auxa Health secures $5.2 in Funding to Drive Benefit Navigation
Largest borrow rate increases among liquid names
First Week of OSCR June 21st Options Trading
2024 Appian Innovation Award Winners Demonstrate Significant Business Results with Next-Gen AI Process Automation